Interaction between Mycobacterium avium and human immunodeficiency virus type 1 (HIV-1) in bronchoalveolar macrophages of normal and HIV-1-infected subjects.

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Interaction between Mycobacterium avium and human immunodeficiency virus type 1 (HIV-1) in bronchoalveolar macrophages of normal and HIV-1-infected subjects.

Am J Respir Cell Mol Biol. 1994 Oct;11(4):487-95. Unique Identifier : AIDSLINE MED/95000691
Denis M; Ghadirian E; Pulmonary Research Unit, Faculty of Medicine, University of; Sherbrooke, Quebec, Canada.

Abstract: Bronchoalveolar lavage (BAL) macrophages from patients with symptomatic or asymptomatic HIV-1 infections were obtained, and their ability to restrict in vitro the growth of an AIDS-associated strain of Mycobacterium avium was compared with cells obtained from normal volunteers. BAL macrophage populations from HIV-1-infected subjects (symptomatic or asymptomatic) spontaneously released significant amounts of IL-6, IL-1 beta, and TNF-alpha, whereas BAL macrophages from normal volunteers released very low amounts of these cytokines. Phagocytosis of M. avium was shown to be similar in both HIV-1-infected subjects and in control subjects. BAL macrophages from HIV-1-infected subjects released significantly greater quantities of IL-6, IL-1 beta, and TNF-alpha than did cells from normal volunteers upon M. avium ingestion. Growth of M. avium was similar in BAL macrophages from all three subject groups. Finally, BAL macrophages from normal volunteers were obtained, and these cells were doubly infected with a macrophage tropic isolate of HIV-1 at a low multiplicity of infection and with an AIDS-associated strain of M. avium. There were no significant differences in cytokine release by cells co-infected with M. avium and HIV-1 and cells infected with M. avium alone. The growth of mycobacteria and the viral replication in doubly infected cells were compared with those in cells infected with only one of the pathogens, and it was shown that HIV-1 infection had no significant effect on M. avium growth.(ABSTRACT TRUNCATED AT 250 WORDS)

Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY Bronchoalveolar Lavage Fluid/CYTOLOGY Cells, Cultured Comparative Study Enzyme-Linked Immunosorbent Assay Female Human HIV Infections/COMPLICATIONS/*IMMUNOLOGY/VIROLOGY HIV-1/*IMMUNOLOGY/PHYSIOLOGY Interleukin-1/METABOLISM Interleukin-6/METABOLISM Macrophages, Alveolar/*IMMUNOLOGY/MICROBIOLOGY/VIROLOGY Male Mycobacterium avium/GROWTH & DEVELOPMENT/*IMMUNOLOGY Mycobacterium avium-intracellulare Infection/COMPLICATIONS/ *IMMUNOLOGY/MICROBIOLOGY Support, Non-U.S. Gov't Tumor Necrosis Factor/METABOLISM Virus Replication/IMMUNOLOGY JOURNAL ARTICLE
950130
M9510852

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .